Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Scenes From A Shutdown: US FDA Hides It Well

Jan 21 2019

• By Derrick Gingery

FDABldg1ExteriorWithCircle_1200x675

Related Content

What If FDA Actually Shuts Down?

Jan 13 2019

Shutdown Week Three: Sponsors With Upcoming User Fee Dates Should Start Sweating

Jan 08 2019

The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

Apr 08 2018

Peter Stein Takes Short Path To Director Of US FDA Drug Office

Dec 10 2018

Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases

Jan 14 2019

Sanofi's Sotagliflozin: Risk Of Ketoacidosis Divides US FDA Advisory Committee

Jan 18 2019

Evenity Likely Headed For Approval With Amgen's Proposed Indication, But Postmarketing Requirements Remain Unclear

Jan 17 2019

US Federal Courts Can Operate Until Jan. 25; Patent Office Faces Eminent Closure Under Shutdown

Jan 17 2019

Related Companies

Sanofi

Lexicon Pharmaceuticals, Inc.

Additional Topics

United States FDA Leadership Regulation Review Pathway Drug Review Advisory Committees BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window